Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

LMI

LMI Joins DoD-Sponsored MxD Manufacturing Research Institute

LMI has become a member of a Department of Defense-funded national institute that aims to equip domestic manufacturers with digital tools and approaches to address military technology manufacturing challenges.

Lockheed Martin

Lockheed Books Potential $88M F-35 Logistics Network Modernization IDIQ

The U.S. Navy has awarded Lockheed Martin (NYSE: LMT) a potential two-year, $87.5M contract to help transition a worldwide logistics information system for F-35 aircraft into a cloud-based integrated network.